rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
1995-5-26
|
pubmed:abstractText |
Membrane-derived lipid mediators have been considered to play a major role in pathogenesis of bronchial asthma. However, the importance of and the interactions among each mediator are still unclear. We examined the role of thromboxane A2 (TXA2) and platelet-activating factor (PAF) in immediate asthmatic response (IAR) and interactions between these lipid mediators in guinea pig airway in vivo using a specific TXA2 antagonist S-1452 and a specific PAF antagonist Y-24180. We confirmed the activity of each antagonist, as S-1452 and Y-24180 significantly and dose-dependently inhibited bronchoconstriction induced by respective agonist inhalation. S-1452 inhibited IAR but Y-24180 did not, indicating that TXA2 plays a major role in IAR but PAF does not. S-1452 significantly inhibited PAF-induced bronchoconstriction but Y-24180 did not inhibit synthesized TXA2 (STA2)-induced bronchoconstriction, showing that the bronchoconstrictive effect of PAF is at least in part dependent on secondarily released TXA2, but TXA2 does not induce PAF production.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens,
http://linkedlifedata.com/resource/pubmed/chemical/Azepines,
http://linkedlifedata.com/resource/pubmed/chemical/Bicyclo Compounds,
http://linkedlifedata.com/resource/pubmed/chemical/Fatty Acids, Monounsaturated,
http://linkedlifedata.com/resource/pubmed/chemical/Platelet Activating Factor,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Prostaglandin,
http://linkedlifedata.com/resource/pubmed/chemical/S 145,
http://linkedlifedata.com/resource/pubmed/chemical/STA 2,
http://linkedlifedata.com/resource/pubmed/chemical/Thromboxane A2,
http://linkedlifedata.com/resource/pubmed/chemical/Triazoles,
http://linkedlifedata.com/resource/pubmed/chemical/Y 24180
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0929-7855
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
11
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1-12
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7728413-Administration, Inhalation,
pubmed-meshheading:7728413-Animals,
pubmed-meshheading:7728413-Antigens,
pubmed-meshheading:7728413-Asthma,
pubmed-meshheading:7728413-Azepines,
pubmed-meshheading:7728413-Bicyclo Compounds,
pubmed-meshheading:7728413-Bronchoconstriction,
pubmed-meshheading:7728413-Dose-Response Relationship, Drug,
pubmed-meshheading:7728413-Fatty Acids, Monounsaturated,
pubmed-meshheading:7728413-Guinea Pigs,
pubmed-meshheading:7728413-Hypersensitivity,
pubmed-meshheading:7728413-Male,
pubmed-meshheading:7728413-Platelet Activating Factor,
pubmed-meshheading:7728413-Receptors, Prostaglandin,
pubmed-meshheading:7728413-Thromboxane A2,
pubmed-meshheading:7728413-Triazoles
|
pubmed:year |
1995
|
pubmed:articleTitle |
Role of thromboxane A2 and platelet-activating factor in allergic bronchoconstriction in guinea pig airway in vivo.
|
pubmed:affiliation |
Third Department of Internal Medicine, Kanazawa University School of Medicine, Japan.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|